Comparative risk of seizure with use of first- And Second-Generation antipsychotics in patients with Schizophrenia and mood disorders

Journal of Clinical Psychiatry

Volumn 77, Issue 5, 2016, Pages e573-e579

  Wu, Chi Shin ^a,b   Wang, Sheng Chang ^c   Yeh, I Jin ^d   Liu, Shi Kai ^d,e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c Center for Neuropsychiatric Research   (Taiwan)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CHLORPROMAZINE; CHLORPROTHIXENE; CLOTIAPINE; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PERPHENAZINE; PROCHLORPERAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE; ZIPRASIDONE; ZOTEPINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; ICD-9-CM; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SEIZURE; SENSITIVITY ANALYSIS; TAIWAN; CHEMICALLY INDUCED; CROSS-SECTIONAL STUDY; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; RISK; SEIZURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; SCHIZOPHRENIA; SEIZURES; TAIWAN; YOUNG ADULT;

EID: 84973470335     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m09898     Document Type: Article

References (26)

1. Hedges D, Jeppson K, Whitehead P. Antipsychotic medication and seizures: A review. Drugs Today (Barc). 2003;39(7):551-557. doi:10.1358/dot.203.39.7.7945 PubMed.
2. Pisani F, Oteri G, Costa C, et al. Effects of psychotropic drugs on seizure threshold. Saf. 2002;25(2):91-110.doi:10.2165/02018-2025020-04 PubMed.
3. Hashimoto K, Sudo T, Hirano M, et al. Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia. Schizophr Res. 2006;87(1-3):332-333. doi:10.1016/j.schres.206.03.048 PubMed.
4. Hedges DW, Jeppson KG. New-onset seizure associated with quetiapine and olanzapine. Ann Pharmacother. 2002;36(3):437-439. doi:10.1345/aph.1A207 PubMed.
5. Malik AR, Ravasia S. Aripiprazole-induced seizure. Can J Psychiatry. 2005;50(3):186. PubMed.
6. Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: A meta-analysis of placebo-controlled randomized trials. Am J Psychiatry. 2009;166(9):980-991. doi:10.176/api.ajp.209.09030312 PubMed.
7. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15(1):1-44. doi:10.1/bdi.12025 PubMed.
8. Alper K, Schwartz KA, Kolts RL, et al. Seizure incidence in psychopharmacological clinical trials: An analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62(4):345-354. doi:10.1016/j.biopsych.206.09.023 PubMed.
9. Kumlien E, Lundberg PO. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database. Seizure. 2010;19(2):69-73. doi:10.1016/j.seizure.209.1.05 PubMed.
10. Lertxundi U, Hernandez R, Medrano J, et al. Antipsychotics and seizures: higher risk with atypicals? Seizure. 2013;22(2):141-143. doi:10.1016/j.seizure.2012.10.09 PubMed.
11. Chen YH, Chiou HY, Lin HC, et al. Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. Arch Neurol. 2009;66(8):979-984. doi:10.101/archneurol.209.142 PubMed.
12. Hsieh CY, Lai EC, Yang YH, et al. Comparative stroke risk of antiepileptic drugs in patients with epilepsy. Epilepsia. 2013;54(1):172-180. doi:10.1/j.1528-167.2012.03693.x PubMed.
13. World Health Organization. WHO Collaborating Centre for Drug Statistic Methodology: Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: World Health Organization; 2009.
14. Patorno E, Bohn RL, Wahl PM, et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA. 2010;303(14):1401-1409. doi:10.101/jama.2010.410 PubMed.
15. Schneeweiss S, Rassen JA, Glynn RJ, et al. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20(4):512-522. doi:10.1097/EDE.0b013e3181a63c PubMed.
16. Shui IM, Shi P, Dutta-Linn MM, et al; Vaccine Safety Datalink Research Team. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine. 2009;27(39):5307-5312. doi:10.1016/j.vacine.209.06.092 PubMed.
17. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993;34(3):453-468. doi:10.1/j.1528-157.193.tb02586.x PubMed.
18. Centorrino F, Price BH, Tuttle M, et al. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry. 2002;159(1):109-115. doi:10.176/api.ajp.159.1.109 PubMed.
19. Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology. 1991;41(3):369-371. doi:10.1212/WNL.41.3.369 PubMed.
20. Pacia SV, Devinsky O. Clozapine-related seizures: Experience with 5, 629 patients. Neurology. 1994;44(12):2247-2249. doi:10.1212/WNL.4.12.247 PubMed.
21. Spring GK. Neurotoxicity with combined use of lithium and thioridazine. J Clin Psychiatry. 1979;40(3):135-138. PubMed.
22. Chang WH, Jann MW, Hwu HG, et al. Ethnic comparison of haloperidol and reduced haloperidol plasma levels: Taiwan Chinese versus American non-Chinese. J Formos Med Assoc. 1991;90(6):572-578. PubMed.
23. Jann MW, Chang WH, Davis CM, et al. Haloperidol and reduced haloperidol plasma levels in Chinese vs non-Chinese psychiatric patients. Psychiatry Res. 1989;30(1):45-52. doi:10.1016/0165-1781(89)90170-4 PubMed.
24. Abilify (aripiprazole) tablets [package insert]. Tokyo, Japan: Otsuka Pharmaceutical, Co, Ltd: 2016.
25. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43-46. doi:10.1097/01648-19010-010 PubMed.
26. Murphy K, Delanty N. Drug-induced seizures. CNS Drugs. 2000;14(2):135-146. doi:10.2165/023210-2014020-04.